Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.

Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.

Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.

Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.

The latest research on pneumonic plague, respiratory syncytial virus (RSV) and other life-threatening infections will be discussed during a Symposium on Infection and Immunity April 11 at the Vanderbilt Student Life Center.